HOME >> BIOLOGY >> NEWS
Prostate Cancer Switch May Yield Map Of Cancer Machinery, Targets For Drugs

DURHAM, N.C. -- A team of molecular biologists has pinpointed a genetic switch in prostate cancer cells that may play a role in triggering a quiescent tumor to erupt into an invasive, deadly cancer that spreads throughout the body.

The scientists said discovery of this single genetic switch could open a research pathway that might well lead to a road map of the complex changes prostate cancer cells undergo in their progression to a deadly form. Such a road map would yield not only molecular markers that would allow physicians to better pinpoint the stage of a prostate cancer, but also new drugs to kill cancer cells at earlier stages, the researchers said.

Prostate cancers are distinguished by their tendency to linger at a relatively benign stage for many years, but to suddenly transform into a deadly form that spreads, or metastasises, throughout the body.

The scientists are Russ Carstens and Mariano Garcia-Blanco of the Duke University Medical Center department of pharmacology and cancer biology, and Wallace McKeehan of Texas A&M University. They published their findings in the April issue of Molecular and Cellular Biology. Their work is supported by the National Institutes of Health, the Duke Comprehensive Cancer Center, the American Heart Association and the Keck Foundation, which supports the Levine Science Research Center, where the work was performed.

Working with rat prostate cancer cells, the scientists discovered the molecular basis for a genetic switch that governs whether a cancer cell generates one or another form of a protein receptor molecule called FGF-R2 (Fibroblast Growth Factor Receptor 2) that festoons the surface of the cell.

These receptors are molecular locks, into which fits a protein called a growth factor, secreted by another cell in the prostate. As long as the FGF-R2 receptor is of one type -- called IIIb -- the cancer cell is relatively
'"/>

Contact: Dennis Meredith
Dennis@dukenews.duke.edu
919-681-8054
Duke University
25-Mar-1998


Page: 1 2 3

Related biology news :

1. Prostate cancer test works as well for black men, study shows
2. Renowned Prostate Cancer Experts Present Latest Findings At UCSF Cancer Center Symposium
3. Seattle Researchers Zero In On Location Of Gene For Inherited Prostate Cancer; Gene Also Linked To Brain Cancer
4. Common Prostate Cancer: A Different Process Altogether?
5. Plant-Based Fat May Reduce Risk Of Prostate Cancer By Altering Testosterone Metabolism, UB Study Shows
6. Study Of Protein Reveals Two Different Prostate Cancers;One More Deadly Also Shows That Benign Prostate Hyperplasia Not A Precursor To Prostate Cancer
7. Penn Researchers Find Mutation In Prostate Cancer Gene
8. A New Molecular Marker For Prostate Cancer
9. Duration Of Pre-Clinical Prostate Cancer Based On Serial PSA Data From The VA Normative Aging Study
10. PSA Levels Mean More Extensive Prostate Disease In Older Men
11. New Test May Reduce Need For Some Prostate Cancer Biopsies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2019)... (PRWEB) , ... August 19, 2019 , ... ... characterized tissues through the use of ultra-thin two dimensional slices which are placed ... be highly limited for complex tissues and complicated features such as vasculature and ...
(Date:8/15/2019)... ... 2019 , ... Serialization deadlines in the US and European ... aggregation becomes fully applied in the United States in 2023, pharmaceutical companies are ... now, most regulations?including the Drug Supply Chain Security Act (DSCSA)?have required minimal system ...
(Date:8/14/2019)... (PRWEB) , ... August 14, 2019 , ... ... broadcast 4Q/2019, will explore how developments in microbiome therapeutics are helping to promote ... listings for more information. , Advancements will educate about the DECODE.DESIGN.CURE™ technology platform, ...
Breaking Biology News(10 mins):
(Date:9/11/2019)... Pa. (PRWEB) , ... September 09, 2019 , ... ... Response Technology (IRT) for clinical trial randomization and drug supply chain management, today ... provider for the global life sciences industry. , “The integration between Veeva Vault ...
(Date:9/8/2019)... (PRWEB) , ... September 04, 2019 , ... ... York Academy of Sciences announced today the three Winners and six Finalists ... postdoctoral scientists from academic research institutions across New York, New Jersey, and Connecticut ...
(Date:8/29/2019)... ... August 29, 2019 , ... Scientists ... a feat they hope will ultimately help protect the multibillion-dollar grape industry that ... Institute of Technology faculty and alumni sequenced the microbiome found within tumors of ...
(Date:8/27/2019)... ... 27, 2019 , ... Modality Solutions , an Inc. ... Consulting Engineer, Robert Battista, to Senior Consulting engineer. , In his new leadership ... new engineers as well as the creation of additional business opportunities and cutting-edge ...
Breaking Biology Technology:
Cached News: